FDA EIR - BioMarin Pharmaceutical Inc. - February 28, 2020

BioMarin Pharmaceutical Inc. in San Rafael, CA, was the subject of an FDA Establishment Inspection from February 24 to February 28, 2020. This report summarizes the findings of that inspection. The document indicates a summary (DPT) is included, but the provided text only contains header information and a table of contents, not the detailed inspection observations or violations themselves. Therefore, specific main violations/issues, regulatory framework, or required actions cannot be definitively identified from the available content. The inspection likely assessed the company's compliance with good manufacturing practices, but without the full body of the report, further details remain unstated. The document serves as a record of the inspection's initiation and conclusion dates for BioMarin Pharmaceutical Inc.